Improving Pharmacist-Led Pediatric Patient Education on Oral Chemotherapy at Home

Author:

Patel Anika1ORCID,Nguyen Christopher M.1,Willins Kristin1,Wang Elsabella Y.2,Magedman Grace3,Yang Sun1ORCID

Affiliation:

1. School of Pharmacy, Chapman University, Irvine, CA 92618, USA

2. Herbert Wertheim School of Public Health, University of California San Diego, San Diego, CA 92093, USA

3. CHOC Children’s Hospital, Orange, CA 92868, USA

Abstract

Oral chemotherapy (OC) has been increasingly used in pediatric patients diagnosed with cancer, which is primarily managed in the outpatient setting. Different from adults, pediatric patients face unique challenges in administering these hazardous medications at home. Because of the complexity of pediatric pharmaceutical care and the hazardous nature of chemotherapy agents, comprehensive patient education is imperative to mitigate the potential safety risks associated with OC administration at home. Pharmacists play a vital role in patient education and medication consultations. However, the lack of practice guidelines and limited resources supporting OC counseling are noted. Additional barriers include insufficient knowledge and training on OC, which can be improved by continuing education. In a regional children’s hospital, a comprehensive OC education checklist was developed for pediatric patients and their caregivers to standardize consultations led by pharmacists. An infographic OC handout was also formulated to improve patient knowledge and awareness. Moreover, innovative approaches such as using telepharmacy, smartphone applications, and artificial intelligence have been increasingly integrated into patient care, which can help optimize OC consultations for children and adolescents. Further studies are warranted to enhance oral chemotherapy education specifically tailored for pediatric patients in outpatient settings.

Funder

Chapman University School of Pharmacy

Publisher

MDPI AG

Subject

Pediatrics, Perinatology and Child Health

Reference75 articles.

1. FDA (2022, August 18). New Drug Therapy Approvals 2020, Available online: https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/new-drug-therapy-approvals-2020.

2. Oral Oncolytics Will Require Health Care System to Adapt;Alwardt;OncologyLive,2020

3. NCCN Task Force Report: Oral chemotherapy;Weingart;J. Natl. Compr. Cancer Netw.,2008

4. Molecular targeted therapy for anticancer treatment;Min;Exp. Mol. Med.,2022

5. Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives;Zhong;Signal Transduct. Target. Ther.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3